KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Debt (2016 - 2025)

Charles River Laboratories International has reported Total Debt over the past 17 years, most recently at $2.1 billion for Q4 2025.

  • Quarterly results put Total Debt at $2.1 billion for Q4 2025, down 4.64% from a year ago — trailing twelve months through Dec 2025 was $2.1 billion (down 4.64% YoY), and the annual figure for FY2025 was $2.1 billion, down 4.64%.
  • Total Debt for Q4 2025 was $2.1 billion at Charles River Laboratories International, down from $2.2 billion in the prior quarter.
  • Over the last five years, Total Debt for CRL hit a ceiling of $3.0 billion in Q2 2022 and a floor of $2.1 billion in Q4 2025.
  • Median Total Debt over the past 5 years was $2.7 billion (2023), compared with a mean of $2.6 billion.
  • Biggest five-year swings in Total Debt: skyrocketed 34.68% in 2021 and later dropped 15.37% in 2024.
  • Charles River Laboratories International's Total Debt stood at $2.7 billion in 2021, then rose by 1.54% to $2.7 billion in 2022, then decreased by 2.23% to $2.6 billion in 2023, then dropped by 15.37% to $2.2 billion in 2024, then dropped by 4.64% to $2.1 billion in 2025.
  • The last three reported values for Total Debt were $2.1 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.3 billion (Q2 2025) per Business Quant data.